What changed: Peritoneal mesothelioma

Cancer page →

Every dated change on the records linked to Peritoneal mesothelioma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Milestone4This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-16This recordPeritoneal mesothelioma
Facts on this page last checked
When this page itself was last checked or edited.

2021 · 1

2021MilestonePeritoneal mesothelioma
Immunotherapy series in peritoneal disease
Early phase 2 and retrospective data for nivolumab plus ipilimumab and for atezolizumab plus bevacizumab.

2009 · 1

2009MilestonePeritoneal mesothelioma
Multi-institutional registry of 405 patients
Yan and colleagues report median survival of 53 months after cytoreduction and HIPEC.

1995 · 1

1995MilestoneHIPEC / PIPAC (intraperitoneal chemotherapy)
Sugarbaker develops cytoreduction with HIPEC
Peritonectomy procedures and heated intraperitoneal chemotherapy applied to peritoneal surface malignancy.

1908 · 1

1908MilestonePeritoneal mesothelioma
Miller and Wynn describe peritoneal mesothelioma
Among the earliest descriptions of a primary tumour of the peritoneum.